163 related articles for article (PubMed ID: 10790570)
1. Principles of treatment of choroidal neovascularization with photodynamic therapy in age-related macular degeneration.
Donati G; Kapetanios AD; Pournaras CJ
Semin Ophthalmol; 1999 Mar; 14(1):2-10. PubMed ID: 10790570
[TBL] [Abstract][Full Text] [Related]
2. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study.
Schmidt-Erfurth U; Miller JW; Sickenberg M; Laqua H; Barbazetto I; Gragoudas ES; Zografos L; Piguet B; Pournaras CJ; Donati G; Lane AM; Birngruber R; van den Berg H; Strong HA; Manjuris U; Gray T; Fsadni M; Bressler NM
Arch Ophthalmol; 1999 Sep; 117(9):1177-87. PubMed ID: 10496389
[TBL] [Abstract][Full Text] [Related]
3. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.
Arch Ophthalmol; 1999 Oct; 117(10):1329-45. PubMed ID: 10532441
[TBL] [Abstract][Full Text] [Related]
4. Angiographic features after photodynamic therapy for choroidal neovascularisation in age related macular degeneration and pathological myopia.
Parodi MB; Da Pozzo S; Ravalico G
Br J Ophthalmol; 2003 Feb; 87(2):177-83. PubMed ID: 12543747
[TBL] [Abstract][Full Text] [Related]
5. Sequence of early vascular events after photodynamic therapy.
Michels S; Schmidt-Erfurth U
Invest Ophthalmol Vis Sci; 2003 May; 44(5):2147-54. PubMed ID: 12714655
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study.
Miller JW; Schmidt-Erfurth U; Sickenberg M; Pournaras CJ; Laqua H; Barbazetto I; Zografos L; Piguet B; Donati G; Lane AM; Birngruber R; van den Berg H; Strong A; Manjuris U; Gray T; Fsadni M; Bressler NM; Gragoudas ES
Arch Ophthalmol; 1999 Sep; 117(9):1161-73. PubMed ID: 10496388
[TBL] [Abstract][Full Text] [Related]
7. Changes in confocal indocyanine green angiography through two years after photodynamic therapy with verteporfin.
Schmidt-Erfurth UM; Michels S
Ophthalmology; 2003 Jul; 110(7):1306-14. PubMed ID: 12867383
[TBL] [Abstract][Full Text] [Related]
8. Guidelines for using verteporfin (visudyne) in photodynamic therapy to treat choroidal neovascularization due to age-related macular degeneration and other causes.
; ;
Retina; 2002 Feb; 22(1):6-18. PubMed ID: 11884872
[TBL] [Abstract][Full Text] [Related]
9. Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: additional information regarding baseline lesion composition's impact on vision outcomes-TAP report No. 3.
Bressler NM; Arnold J; Benchaboune M; Blumenkranz MS; Fish GE; Gragoudas ES; Lewis H; Schmidt-Erfurth U; Slakter JS; Bressler SB; Manos K; Hao Y; Hayes L; Koester J; Reaves A; Strong HA;
Arch Ophthalmol; 2002 Nov; 120(11):1443-54. PubMed ID: 12427056
[TBL] [Abstract][Full Text] [Related]
10. Verteporfin photodynamic therapy for extrafoveal choroidal neovascularisation secondary to age-related macular degeneration.
Voelker M; Gelisken F; Ziemssen F; Wachtlin J; Grisanti S
Graefes Arch Clin Exp Ophthalmol; 2005 Dec; 243(12):1241-6. PubMed ID: 16010552
[TBL] [Abstract][Full Text] [Related]
11. Intravitreal bevacizumab (Avastin) in combination with verteporfin photodynamic therapy for choroidal neovascularization associated with age-related macular degeneration (IBeVe Study).
Costa RA; Jorge R; Calucci D; Melo LA; Cardillo JA; Scott IU
Graefes Arch Clin Exp Ophthalmol; 2007 Sep; 245(9):1273-80. PubMed ID: 17333238
[TBL] [Abstract][Full Text] [Related]
12. Predictive role of coagulation-balance gene polymorphisms in the efficacy of photodynamic therapy with verteporfin for classic choroidal neovascularization secondary to age-related macular degeneration.
Parmeggiani F; Costagliola C; Gemmati D; D'Angelo S; Perri P; Scapoli GL; Catozzi L; Federici F; Sebastiani A; Incorvaia C
Pharmacogenet Genomics; 2007 Dec; 17(12):1039-46. PubMed ID: 18004208
[TBL] [Abstract][Full Text] [Related]
13. [Novel approach for management of age-related macular degeneration--antiangiogenic therapy and retinal regenerative therapy].
Tamaki Y
Nippon Ganka Gakkai Zasshi; 2007 Mar; 111(3):232-68; discussion 269. PubMed ID: 17402564
[TBL] [Abstract][Full Text] [Related]
14. Fundus autofluorescence before and after photodynamic therapy for choroidal neovascularization secondary to age-related macular degeneration.
Framme C; Bunse A; Sofroni R; Thalhammer T; Walter A; Sachs HG; Gabel VP
Ophthalmic Surg Lasers Imaging; 2006; 37(5):406-14. PubMed ID: 17017200
[TBL] [Abstract][Full Text] [Related]
15. [Photodynamic therapy in age-related macular degeneration--results of one year observation].
Wykrota H; Gierek-Łapińska A
Klin Oczna; 2002; 104(3-4):239-43. PubMed ID: 12608309
[TBL] [Abstract][Full Text] [Related]
16. Guidelines for using verteporfin (Visudyne) in photodynamic therapy for choroidal neovascularization due to age-related macular degeneration and other causes: update.
Verteporfin Roundtable Participants
Retina; 2005; 25(2):119-34. PubMed ID: 15689800
[TBL] [Abstract][Full Text] [Related]
17. Case series outcomes at 1 week following verteporfin photodynamic therapy.
Tan W; Beaumont PE; Chang AA
Retina; 2003 Apr; 23(2):166-70. PubMed ID: 12707594
[TBL] [Abstract][Full Text] [Related]
18. Short-term reaction of choroidal neovascularization and choriocapillaris to photodynamic therapy in age-related macular degeneration.
Eter N; Vogel A; Inhetvin-Hutter C; Spitznas M
Eur J Ophthalmol; 2003 Oct; 13(8):687-92. PubMed ID: 14620172
[TBL] [Abstract][Full Text] [Related]
19. Photodynamic therapy with verteporfin for choroidal neovascularization due to age-related macular degeneration and other causes: a New Zealand outcomes study.
Sharp DM; Lai S; Markey CM
Clin Exp Ophthalmol; 2007; 35(1):24-31. PubMed ID: 17300567
[TBL] [Abstract][Full Text] [Related]
20. Photodynamic therapy for age-related macular degeneration.
Jin C; Ge J; Zhou S; Chen H; Zhong X; Jiang R; Chen L; Chen L
Yan Ke Xue Bao; 2004 Sep; 20(3):158-62. PubMed ID: 15499723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
